Antigua and Barbuda vs Montserrat: Tuberculosis patients living with HIV receiving antiretroviral therapy

Antigua and Barbuda
0 patients
in 2021
Montserrat
0 patients
in 2019
Antigua and Barbuda rank
141st
Montserrat rank
141st

Tuberculosis patients living with HIV receiving antiretroviral therapy over time

  • Antigua and Barbuda
  • Montserrat
012345200320122021

How they compare

Antigua and Barbuda currently reports 0 patients against 0 patients in Montserrat, a difference of 0 patients.

The two have swapped places 4 times across 13 shared years of data; in 2003 it was Montserrat ahead.

Antigua and Barbuda ranks 141st and Montserrat ranks 141st of 183 countries.

Antigua and Barbuda has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Antigua and Barbuda Montserrat Difference Ahead
2000s 1.25 patients 0.5 patients 0.75 patients Antigua and Barbuda
2010s 1.67 patients 0 patients 1.67 patients Antigua and Barbuda

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Antigua and Barbuda or Montserrat?
Antigua and Barbuda, at 0 patients against 0 patients in Montserrat as of 2021.
What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Antigua and Barbuda and Montserrat?
0 patients, with Antigua and Barbuda ahead.
How many years of comparable data are there for Antigua and Barbuda and Montserrat?
13 years are reported by both, from 2003 to 2019.
How do Antigua and Barbuda and Montserrat rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
Antigua and Barbuda ranks 141st and Montserrat ranks 141st of 183 countries.
Where does this data come from?
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Antigua and Barbuda vs Montserrat: Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 14 September 2026, from https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/antigua-and-barbuda/montserrat/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/antigua-and-barbuda/montserrat/">Antigua and Barbuda vs Montserrat: Tuberculosis patients living with HIV receiving antiretroviral therapy</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.